Role within the CfCWR
Professor of Wound Healing at the University of Birmingham. Advising on the basic biology of scarring, the therapeutic manipulation of the phases of wound healing and the commercial, IP and regulatory considerations required to advance scar reduction approaches to the clinic.
Other positions held
- Member of the Healthcare Technologies Institute, Medical Devices Testing and Evaluation Centre and advisor on the development of the Birmingham Life Sciences Park.
- Member of the Editorial Board of The Frontiers in Surgery: Plastic & Reconstructive Surgery and the Editorial Board of Materials in Medicine: Journal of Materials Science.
- Fellow of The Royal Society of Biology
- PhD in Molecular Genetics, University of Lancaster
- BSc (Hons) Biochemistry, University of Lancaster
Healthcare Technologies Institute, Institute of Translational Medicine
Anthony Metcalfe’s research has characterised wound healing and scar reduction, programmed cell death mechanisms in mammary gland biology & pre-implantation development, as well as engineering bispecific antibodies as a therapy for cancer. Tony has worked in academia, industry and the not-for-profit sectors as Professor of Wound Healing at the Universities of Birmingham and Brighton, and worked as Team Leader at The University of Manchester and St Mary’s Hospital, Manchester. He was also Director of Research and Target Biology at Renovo Ltd, F-star Biotechnology Ltd and led The Blond McIndoe Research Foundation. He has developed techniques for creating novel skin substitutes, delivery mechanisms for skin cells and stem cells, has investigated bi-specific antibodies for cancer therapies. He has experience of Phase I trials in Oncology and has developed scar reduction technologies from proof of concept lab-based studies through to multicentre Phase III clinical trials.
Tony has published widely and is a member of the editorial board of The Frontiers in Surgery: Plastic & Reconstructive Surgery and the Editorial Board of Materials in Medicine: Journal of Materials Science.
Tony has been a scientific and commercial advisory panel member for the Technology Strategy Board – Regenerative Medicine / Tools and Technologies, a scientific and clinical advisory panel member to DEBRA and DEBRA International. He has also acted as an advisory reviewer to the Scar Free Foundation and input into their Research Strategy and has acted as Scientific Advisor to the GSK Fibrosis Discovery.